Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.31) per share. This is a 18.42 percent increase over losses of $(0.38) per share from the same period last year. The company reported $13.68 million in sales this quarter. This is a 439.91 percent increase over sales of $2.53 million the same period last year.
‘Amazon Confirms 100% Success Rate For Project Kuiper Protoflight Mission; Project Kuiper On Track To Begin Mass Satellite Production Ahead Of Full-Scale Deployment Starting H1 2024’ – GeekWire
https://www.geekwire.com/2023/amazon-project-kuiper-satellites-ace-space-tests/Amazon's Project Kuiper satellite network streamed its first video and facilitated its first online sale during a monthlong series of orbital
